- Achillion Pharmaceuticals (NASDAQ:ACHN) is up 6% premarket on high volume in response to the prevailing opinion that yesterday's 24% plunge on 4x normal volume was overdone. The AbbVie/Express Scripts deal stoked the biotech/pharma sell-off.
- Previously: Money flowing out of biotech today (Dec. 23)
Achillion set for gap up at the open
Recommended For You
About AAQL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AAQL | - | - |
Antiaging Quantum Living Inc. |